BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8463904)

  • 1. Effect of treatment with glycine and L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency.
    Rinaldo P; Schmidt-Sommerfeld E; Posca AP; Heales SJ; Woolf DA; Leonard JV
    J Pediatr; 1993 Apr; 122(4):580-4. PubMed ID: 8463904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethylmalonic/adipic aciduria: effects of oral medium-chain triglycerides, carnitine, and glycine on urinary excretion of organic acids, acylcarnitines, and acylglycines.
    Rinaldo P; Welch RD; Previs SF; Schmidt-Sommerfeld E; Gargus JJ; O'Shea JJ; Zinn AB
    Pediatr Res; 1991 Sep; 30(3):216-21. PubMed ID: 1945558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.
    Roe CR; Millington DS; Maltby DA; Bohan TP; Kahler SG; Chalmers RA
    Pediatr Res; 1985 May; 19(5):459-66. PubMed ID: 4000772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
    Chalmers RA; Roe CR; Stacey TE; Hoppel CL
    Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acylcarnitine profiles during carnitine loading and fasting tests in a Japanese patient with medium-chain acyl-CoA dehydrogenase deficiency.
    Yokoi K; Ito T; Maeda Y; Nakajima Y; Ueta A; Nomura T; Koyama N; Kato I; Suzuki S; Kurono Y; Sugiyama N; Togari H
    Tohoku J Exp Med; 2007 Dec; 213(4):351-9. PubMed ID: 18075239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of supplementation with L-carnitine at a small dose on acylcarnitine profiles in serum and urine and the renal handling of acylcarnitines in a patient with multiple acyl-coenzyme A dehydrogenation defect.
    Yoshino M; Tokunaga Y; Watanabe Y; Yoshida I; Sakaguchi M; Hata I; Shigematsu Y; Kimura M; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(1):73-82. PubMed ID: 12828999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of urinary carnitine esters in a patient with medium-chain acyl-coenzyme A dehydrogenase deficiency: effect of metabolic state and L-carnitine therapy.
    Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL; Rossi TM; Lebenthal E
    J Pediatr; 1989 Oct; 115(4):577-82. PubMed ID: 2795349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: a pilot study.
    Lee PJ; Harrison EL; Jones MG; Jones S; Leonard JV; Chalmers RA
    J Inherit Metab Dis; 2005; 28(2):141-52. PubMed ID: 15877203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased fasting free fatty acids with L-carnitine in children with carnitine deficiency.
    Schwenk WF; Hale DE; Haymond MW
    Pediatr Res; 1988 May; 23(5):491-4. PubMed ID: 3290828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal handling of carnitine in secondary carnitine deficiency disorders.
    Stanley CA; Berry GT; Bennett MJ; Willi SM; Treem WR; Hale DE
    Pediatr Res; 1993 Jul; 34(1):89-97. PubMed ID: 8356025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of long-term oral L-carnitine administration on insulin sensitivity, glucose disposal, plasma concentrations of leptin and acylcarnitines, and urinary acylcarnitine excretion in warmblood horses.
    Kranenburg LC; Westermann CM; de Sain-van der Velden MG; de Graaf-Roelfsema E; Buyse J; Janssens GP; van den Broek J; van der Kolk JH
    Vet Q; 2014; 34(2):85-91. PubMed ID: 24893614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary acylcarnitines in a patient with neonatal multiple acyl-CoA dehydrogenation deficiency, quantified by a carboxylic acid analyzer with a reversed-phase column.
    Kidouchi K; Niwa T; Nohara D; Asai K; Sugiyama N; Morishita H; Kobayashi M; Wada Y
    Clin Chim Acta; 1988 Apr; 173(3):263-72. PubMed ID: 3383426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of urinary acylglycines and acylcarnitines as diagnostic markers of medium-chain acyl-CoA dehydrogenase deficiency.
    Rinaldo P; O'Shea JJ; Goodman SI; Miller LV; Fennessey PV; Whelan DT; Hill RE; Tanaka K
    J Inherit Metab Dis; 1989; 12 Suppl 2():325-8. PubMed ID: 2512435
    [No Abstract]   [Full Text] [Related]  

  • 14. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy.
    Westermann CM; Dorland L; Votion DM; de Sain-van der Velden MG; Wijnberg ID; Wanders RJ; Spliet WG; Testerink N; Berger R; Ruiter JP; van der Kolk JH
    Neuromuscul Disord; 2008 May; 18(5):355-64. PubMed ID: 18406615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation.
    Treem WR; Stanley CA; Goodman SI
    J Inherit Metab Dis; 1989; 12(2):112-9. PubMed ID: 2502671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.
    Gregersen N; Wintzensen H; Christensen SK; Christensen MF; Brandt NJ; Rasmussen K
    Pediatr Res; 1982 Oct; 16(10):861-8. PubMed ID: 7145508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency.
    Huidekoper HH; Schneider J; Westphal T; Vaz FM; Duran M; Wijburg FA
    J Inherit Metab Dis; 2006 Oct; 29(5):631-6. PubMed ID: 16972171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases.
    Gregersen N; Kølvraa S; Rasmussen K; Mortensen PB; Divry P; David M; Hobolth N
    Clin Chim Acta; 1983 Aug; 132(2):181-91. PubMed ID: 6616873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.